Anthropometric Measurements and Balance in Children With Diabetes Relation Between Anthropometric Measurements and Balance in Children With Type 1 Diabetes

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05575609
Collaborator
(none)
50
1
12.9
3.9

Study Details

Study Description

Brief Summary

Type 1 diabetes mellitus is the most common chronic metabolic disorder in children. Diabetic children who take proper nutrition and good care attain normal growth status. Factors affecting growth in diabetic patients include gender, age at diagnosis, duration of disease, glycemic control, and puberty status. Moreover, diabetes mellitus has negative impact on vestibular system, affect proprioception and lower limb muscle fatigue resulting in reduced balance.

Condition or Disease Intervention/Treatment Phase
  • Other: children with Diabetes Mellitus, Type 1

Detailed Description

Limited literature is available regarding the relation between anthropometric measurements and balance in children with diabetes mellitus. Therefore, the current study will be conducted to investigate the relation between anthropometric measurements (weight, height and body mass index) and balance in children with diabetes mellitus.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Relation Between Anthropometric Measurements and Balance in Children With Type 1 Diabetes
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Outcome Measures

Primary Outcome Measures

  1. balance [baseline assessment]

    HUMAC balance system will be used to assess balance

  2. weight anthropometric measurement [baseline assessment]

    the anthropometric measurement will be conducted using universal weight scale

  3. height anthropometric measurement [baseline assessment]

    the anthropometric measurement will be conducted using universal height scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 11 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed as controlled T1DM.

  • Age ranges from 7 to 11 years.

  • From both sexes.

  • Duration of the disease 3 to < 5 years.

  • Same socioeconomic level.

Exclusion Criteria:
  • Other hormonal diseases (hypothyroidism or hyperthyroidism).

  • Hereditary sensory and autonomic neuropathy

  • Significant visual disorders.

  • Subjects participating in regular sports activities.

  • History of fracture or surgery in the lower extremities in the past 12 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Amira Mahmoud Abd-elmonem Giza Egypt 12662

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Mohamed E Mohamed, B.S.C, Cairo university, faculty of physical therapy
  • Study Chair: Asmaa O Sayed, Phd, Cairo university, faculty of physical therapy
  • Study Director: SHaima A Mohamed, PhD, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amira Mahmoud Abd-elmonem, Assist Prof. Physiacl therapy for pediatric department, faculty of physical therapy , Cairo university, Cairo University
ClinicalTrials.gov Identifier:
NCT05575609
Other Study ID Numbers:
  • diabetes
First Posted:
Oct 12, 2022
Last Update Posted:
Dec 7, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Amira Mahmoud Abd-elmonem, Assist Prof. Physiacl therapy for pediatric department, faculty of physical therapy , Cairo university, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 7, 2022